Revenue
2009
2010
2011
2012
2013
2014
2015
2016
| 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $24.59B | $25.13B | $28.41B | $29.00B | $34.81B | $33.68B | $27.70B | $26.11B | $30.53B |
| Research & development | $1.64B | $1.90B | $1.96B | $2.04B | $2.12B | $1.96B | $1.60B | $1.38B | $1.39B |
| Operating income | — | — | $6.36B | $5.37B | $5.37B | $5.88B | $4.61B | $3.34B | — |
| EBITDAderived | — | — | $7.97B | $6.97B | $7.08B | $7.44B | $5.99B | $4.84B | — |
| Net income | $2.51B | $1.95B | $3.63B | $4.85B | $2.75B | $3.56B | $3.03B | $1.75B | $2.01B |
| Basic EPSper diluted share | $2.87 | $2.17 | $3.95 | $5.22 | $2.94 | $3.82 | $3.32 | $1.93 | $2.21 |
| Diluted EPSper diluted share | $2.85 | $2.16 | $3.92 | $5.18 | $2.91 | $3.77 | $3.28 | $1.92 | $2.20 |